ACHE Antibody
- Known as:
- ACHE Antibody
- Catalog number:
- AF1017a
- Product Quantity:
- 0.1mg
- Category:
- -
- Supplier:
- Abgen
- Gene target:
- ACHE Antibody
Related genes to: ACHE Antibody
- Gene:
- ACHE NIH gene
- Name:
- acetylcholinesterase (Cartwright blood group)
- Previous symbol:
- YT
- Synonyms:
- -
- Chromosome:
- 7q22.1
- Locus Type:
- gene with protein product
- Date approved:
- 1989-06-02
- Date modifiied:
- 2019-04-23
Related products to: ACHE Antibody
Related articles to: ACHE Antibody
- Hereditary Angioedema (HAE) is a rare disease affecting approximately 1 in 50,000 people. It results in angioedema of the skin, abdominal tract and upper airway that results in disfiguration, abdominal pain and potential for asphyxia. Early therapies for HAE have significant drug burden due to intravenous administration (C1-inhibitor) or adverse events (androgens); however, newer therapies have reduced injection requirements, and some are oral. Over the past 6 years two oral therapies have been developed for HAE to include berotralstat for long term prophylaxis (LTP) and sebetralstat for on-demand therapy (ODT). Presently, deucrictibant, another oral HAE therapy, is under investigation and appears effective for LTP and ODT. - Source: PubMed
Publication date: 2026/08/24
Bui VanStone ShaneBhattarai BharoshaLuong Long HoangVu Mai ThiAydin E PelinsuCraig Timothy - PurposeTo analyze the prevalence, accuracy of clinical indicators and related factors of the nursing diagnosis of ineffective breathing pattern (00032) in patients hospitalized due to COVID-19.MethodThis is a cross-sectional study conducted in a public hospital, involving 250 adult hospitalizations between 2020 and 2021. Data were collected retrospectively from electronic medical records. Latent class analysis and multivariate logistic regression were performed to analyze the nursing diagnosis of ineffective breathing pattern.FindingsThe prevalence of the ineffective breathing pattern diagnosis was 62%. The main clinical indicators identified included tachypnea, use of accessory muscles for breathing, abdominal paradoxical breathing pattern, and hypoxemia. Latent class analysis indicated that the three-class model was the most suitable, with Class 3 showing the highest prevalence. Indicators such as tachypnea and use of accessory muscles demonstrated high sensitivity, while hypoxemia exhibited high specificity. The presence of fatigue, pain, body position that inhibits lung expansion, and obesity significantly increased the likelihood of the ineffective breathing pattern diagnosis.ConclusionsThe diagnosis of ineffective breathing pattern is prevalent in patients hospitalized with COVID-19, with precise clinical indicators. Fatigue, pain, inadequate body position, and obesity were associated factors.Implications for Nursing PracticeThe clinical validation of the ineffective breathing pattern diagnosis in the population of individuals infected with SARS-CoV-2 is essential for improving the level of evidence. Additionally, it contributes to the nurse's diagnostic inference in clinical practice and decision making for appropriate treatment. - Source: PubMed
Publication date: 2026/08/24
Dos Santos Caio Rodrigo Menezesde Jesus Santos ThiagoVaez Andreia Centenaroda Conceição Araújo Damião - - Source: PubMed
Publication date: 2026/08/24
Mathew Joseph PWilson Sylvia HReves J G - - Source: PubMed
Publication date: 2026/08/24
von Ungern-Sternberg Britta SHauser NeilFarrell Tanya - To compare the outcomes of three different therapeutic modalities in acute adenoviral conjunctivitis. - Source: PubMed
Publication date: 2026/08/24
Thakur AnchalSharma Surya PChauhan PoonamGoyal KapilSingh Mini PSingh NirbhaiRatho R KMalhotra ChintanGupta Amit